Cancer Information

VIDEOS

Clinical Trials Experiences Through Storytelling - Melinda Bachini - So Grateful for Time

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...

Clinical Trials Experiences Through Storytelling - Melinda Bachini - Lifting the Barriers

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...

Clinical Trials Experiences Through Storytelling - Melinda Bachini - The Miracle of a Clinical Trial

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...

Clinical Trials Experiences Through Storytelling - Melinda Bachini - C-Day

We are proud to present this series on Clinical Trials Experiences. This unique patient education program gives a voice to patients with experience in...

2021 COVID PANEL Q1 COVID 19 Variants and the Challenge for Cancer Care

In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have continued candid...

ARTICLES

Understanding Multiple Myeloma: A Patient Guide

As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).

What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.

Meet the 2025 Patient Education Ambassadors!

GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26...

2025 Foro de Pacientes de Terapias Dirigidas de Cancer de Pulmon

Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...

2025 Foro de Pacientes de Terapias Dirigidas de Cancer de Pulmon

Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...

ONLINE COMMUNITY

Worried about a pancoast tumor

Hello I'm 30 years old and have been a smoker for 15 years. Around this time last year (November/December), I started experiencing occasional chest...

Lung cancer onctalk 2024 on demand

Hello, Has anyone watched the Lung Cancer OncTalk 2024 On Demand sessions yet? I’m curious if the content offers any new insights or updates compared...

Complete Video Series 2025 Spanish Targeted Therapies Forum - Thanks to Our Sponsors
Our new videos from the 2025 Spanish Targeted Therapies Forum have just been published. A special thank you goes out to our sponsors: Takeda and...
Can lung cancer be asymptomatic?

Hello, I was diagnosed with stage three sarcoma (MFH) in my left thigh. I underwent five weeks of radiation followed by a resection, and all the...

Tell Your Story-Clinical Trials

Sharing experiences is vital to our learning. Getting a perspective from someone who has been there is often more valuable than getting info through...

Recent Comments

Lung Cancer OncTalk — Pre-Webinar Learning Guide
Oligometastatic vs Oligoprogression
Comment By JanineT GRACE … on Dec 8, 2025 3:29 pm
Four Year Post Updates
Hi Stan!! and happiest of holidays!
Comment By dbrock on Dec 8, 2025 12:05 pm
Lung Cancer OncTalk — Pre-Webinar Learning Guide
Bispecific Drugs
Comment By JanineT GRACE … on Dec 8, 2025 3:29 pm
Lung Cancer OncTalk — Pre-Webinar Learning Guide
ADCs/Antibody-Drug Conjugates
Comment By JanineT GRACE … on Dec 8, 2025 3:29 pm

Terapias Dirigidas de Cáncer de Pulmón 2023 - Panel de Discusión - Parte 2

Video

En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras.

En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. 

Terapias Dirigidas de Cáncer de Pulmón 2023 - Panel de Discusión - Parte 1

Video

En este foro anual de pacientes en vivo, los principales oncólogos torácicos de todo el mundo discuten temas relevantes para los objetivos del cáncer de pulmón, así como mutaciones raras.

En esta serie de videos los Doctores Fernando Diaz, Luis Raez, Luis Corrales, Estelamari Rodriguez y Alberto Chiappori presentan el Panel de Discusión donde hablan sobre temas relevantes del cáncer de pulmón. 

ONDEMAND Videos Available for the 2023 Targeted Therapies in Lung Cancer Patient Forum

Article

Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum!

The full unedited versions of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage and Second Stage, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks.

 

Please note! We have extended the application period - apply before July 15 to be a part of the Clinical Trials Experiences Through Storytelling - Patient Perspectives 2023-24 Program

Article
Please note!  We have extended the application deadline! Apply by July 15, 2023 to be considered!
We are excited to launch our third year of this program; tell your story and help us help others!

Apply Online Now for this paid opportunity to tell your story!

 

Apply Now! Be a Part of the Clinical Trials Experiences Through Storytelling - Patient Perspectives 2023-24 Program

Article
We are excited to launch our third year of this program; tell your story and help us help others!

Apply Online Now for this paid opportunity to tell your story!

 

 

GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview

 

IMA

Discussion Topic
General NSCLC

In 2020 I had left lower lobectomy for a single nodule 17 mm x11 mm with diagnosis of Invasive mucinous adenocarcinoma. No lymph or pleural involvement but STAS was present according to pathology report. Subsequent scans have shown a very small nodule in upper left lobe which is “slightly more conspicuous”. My surgeon has ordered Ct with contrast for my next scan in December. I had a repeat VATS two weeks after the first surgery due to a rather large hemothorax 1.8 liters and had a transfusion.

Subscribe to Survivorship